Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07160790
PHASE3
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
Sponsor: Onconic Therapeutics Inc.
View on ClinicalTrials.gov
Summary
This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD
Official title: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux(NERD) Disease: Double-blind, Randomized
Key Details
Gender
All
Age Range
19 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
321
Start Date
2025-09-02
Completion Date
2026-06-30
Last Updated
2025-09-08
Healthy Volunteers
No
Interventions
DRUG
JP-1366 + placebo
taking JP-1366 + placebo
DRUG
Placebo + Placebo
taking placebo + placebo